These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 4607286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Theophylline toxicity induced by tetracycline.
    McCormack JP, Reid SE, Lawson LM.
    Clin Pharm; 1990 Jul; 9(7):546-9. PubMed ID: 2376112
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical significance of determining theophylline concentration in serum].
    Bonelli J, Dellinger C, Kraus M, Waginger H, Zanic P.
    Wien Med Wochenschr; 1986 Dec 31; 136(23-24):641-6. PubMed ID: 3564492
    [No Abstract] [Full Text] [Related]

  • 4. [Microcrystallinic theophylline, plasma concentration and adverse effects in patients with obstructive lung disease].
    Talseth T, Kongerud J, Boye NP, Bredesen JE.
    Tidsskr Nor Laegeforen; 1981 Oct 20; 101(29):1648-50. PubMed ID: 7339948
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of erythromycin stearate on serum theophylline concentration in patients with chronic obstructive lung disease.
    Stults BM, Felice-Johnson J, Higbee MD, Hardigan K.
    South Med J; 1983 Jun 20; 76(6):714-8. PubMed ID: 6857302
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V, Nicora M, Beretta A.
    Int J Clin Pharmacol Res; 1987 Jun 20; 7(5):337-44. PubMed ID: 3667006
    [Abstract] [Full Text] [Related]

  • 9. How many plasma theophylline levels are needed to control therapy?
    Ullah MI.
    Br J Clin Pract Suppl; 1984 Jun 20; 32():32. PubMed ID: 6432023
    [No Abstract] [Full Text] [Related]

  • 10. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease.
    Dull WL, Alexander MR, Sadoul P, Woolson RF.
    Am Rev Respir Dis; 1982 Oct 20; 126(4):656-9. PubMed ID: 6751178
    [Abstract] [Full Text] [Related]

  • 11. Use of theophylline in the treatment of COPD.
    Ramsdell J.
    Chest; 1995 May 20; 107(5 Suppl):206S-209S. PubMed ID: 7743828
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Theophylline in stable chronic airflow obstruction. A reappraisal.
    Dull WL, Alexander MR.
    Arch Intern Med; 1984 Dec 20; 144(12):2399-401. PubMed ID: 6391407
    [Abstract] [Full Text] [Related]

  • 14. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
    Harder S, Staib AH, Stauder J.
    Prax Klin Pneumol; 1985 Jun 20; 39(6):193-6. PubMed ID: 4022931
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D.
    Br J Clin Pract Suppl; 1984 Jun 20; 32():14-7. PubMed ID: 6432017
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.